Form 10-K · Annual report
Broadridge Financial Solutions 10-K, filed Aug 4, 2026
- Filed
- CIK
- 0001383312
- Accession no.
- 0001628280-26-052243
Summary
Broadridge Financial Solutions acquired four businesses, including CQG, Acolin, iJoin, and Signal, for an aggregate purchase price of $300.2 million in cash ($282.8 million net of cash acquired) in fiscal 2026, and it had $3,787.8 million of goodwill as of June 30, 2026.
Key points
- Broadridge operates in two reportable segments: Investor Communication Solutions (ICS) and Global Technology and Operations (GTO).
- The company acquired four businesses in fiscal 2026, including CQG, Acolin, iJoin, and Signal, for an aggregate purchase price of $300.2 million in cash ($282.8 million net of cash acquired).
- Broadridge had $3,787.8 million of goodwill as of June 30, 2026.
- Broadridge's Investor Communication Solutions business processes the greatest number of proxy materials and annual reports in its third and fourth fiscal quarters, making those quarters higher in revenue, operating income, net earnings, and operating cash flow.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations This discussion summarizes the significant factors affecting the results of operations and financial condition of Broadridge during the fiscal years ended June 30, 2026 and 2025, and should be read in conjunction with our Consolidated Financial Statements and accompanying Notes thereto included elsewhere herein. Certain information contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.